Year

2012

Status

Active

 

Team

Field

Drug delivery technology; oncology therapeutic

Location

Maastricht (The Netherlands)

Fund

BGV II

Cristal Therapeutics

Cristal Therapeutics develops, a new class of nanomedicines based on its proprietary polymeric technologies with an optimized drug disposition and a more favorable tolerability profile.